LIU Hong and HUANG He from Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, identified the novel target of hyperlipidemia, and developed a novel lipid-lowering small compound DC371739, which showed a promising lipid-lowering effect in vitro and in ...

Chinese scientists will conduct the second-phase clinical trial of a new drug to treat lupus, an autoimmune disease, the Chinese Academy of Sciences (CAS) said. The new drug SM934 is a water-soluble artemisinin derivative developed by researchers with the Shanghai Institu...